Ipamorelin
Email me when the evidence changesComparisons
ComparisonsIbutamoren vs ipamorelin: mechanism, evidence, and dosingIbutamoren is an oral ghrelin mimetic with a long half-life; ipamorelin is an injectable, more selective GH secretagogue. Here's what the research actually shows.Read guide →ComparisonsIpamorelin vs sermorelin: how the two GH peptides compareIpamorelin and sermorelin both raise GH but work on different receptors. Compare mechanism, selectivity, evidence, and practical differences here.Read guide →ComparisonsAOD 9604 vs ipamorelin: mechanisms, evidence, and use casesAOD 9604 targets fat metabolism via a lipolytic HGH fragment; ipamorelin stimulates whole GH pulses via ghrelin receptor agonism. Here's how the evidence compares.Read guide →ComparisonsCJC-1295, ipamorelin vs tesamorelin: how they actually differCJC-1295/ipamorelin and tesamorelin both raise GH via different receptors. Compare mechanism, evidence, and dosing logic before deciding what fits your goal.Read guide →ComparisonsGHRP-2 vs ipamorelin: how the two GH secretagogues differGHRP-2 raises cortisol, prolactin, and appetite; ipamorelin is selective for GH. Here's what the receptor pharmacology and human data actually show.Read guide →ComparisonsHexarelin vs ipamorelin: how these two GH secretagogues differBoth hit the ghrelin receptor, but hexarelin is stronger and less selective. Compare mechanism, cortisol/prolactin effects, and evidence for each.Read guide →ComparisonsIpamorelin vs tesamorelin: how the two peptides actually differIpamorelin is a selective ghrelin mimetic; tesamorelin is a GHRH analog approved by FDA for HIV lipodystrophy. Here's how mechanism, evidence, and dosing compare.Read guide →ComparisonsIpamorelin peptide vs tesamorelin peptide: how they differIpamorelin and tesamorelin work through different mechanisms. Compare receptor targets, evidence base, side effects, and why they're often combined.Read guide →ComparisonsIpamorelin vs CJC-1295: what actually differsIpamorelin and CJC-1295 hit different GH pathways (ghrelin mimetic vs GHRH analog). Here's the mechanism, evidence, and stacking logic, sourced from primary studies.Read guide →ComparisonsIpamorelin vs ghrp-6: mechanism, evidence, and dosing differencesBoth are ghrelin mimetics, but ipamorelin is receptor-selective and GHRP-6 spikes cortisol and appetite. Here's the actual receptor and trial data.Read guide →ComparisonsIpamorelin vs hexarelin: how the two secretagogues differIpamorelin is a selective GH secretagogue with minimal cortisol or prolactin effect; hexarelin is more potent but less selective. Full comparison and evidence.Read guide →ComparisonsIpamorelin vs hgh: how the two actually compareIpamorelin nudges your own pituitary to release GH in pulses; HGH injects the hormone directly. Here's what the research actually shows about each.Read guide →ComparisonsIpamorelin vs ibutamoren: mechanism, evidence, and risk comparedIpamorelin and ibutamoren both raise GH and IGF-1, but they differ in receptor selectivity, route, legal status, and side effect profile. Full comparison.Read guide →ComparisonsIpamorelin vs MK-677: how the two GH secretagogues differIpamorelin is a selective injectable GHRP; MK-677 is an oral ghrelin mimetic with a longer half-life. Compare mechanism, evidence, and side effect data here.Read guide →ComparisonsIpamorelin vs tesamorelin: how the two peptides actually differIpamorelin and tesamorelin work on different receptors with different evidence bases. Here's the mechanism, dosing, and safety comparison, backed by studies.Read guide →ComparisonsMK-677 vs ipamorelin: mechanism, evidence, and safetyMK-677 is an oral ghrelin mimetic with a long half-life; ipamorelin is an injectable, more selective GH secretagogue. Here's what the research actually shows.Read guide →ComparisonsTesamorelin peptide vs ipamorelin: what's the difference?Tesamorelin is a GHRH analog, ipamorelin is a ghrelin mimetic. They hit different receptors and are often combined. Here's the mechanism-level comparison.Read guide →